PayPal Longer Deserves Premium? Here’s Why Not Now
PayPal used to attract a premium multiple, but the growth narrative has cooled. This article breaks down the data, co...
What Goes Into Sp 500 Index Value
An intro to the components behind the S&P 500 index value, including inputs and how they combine to form the level.
27,867 articles
Price Prediction: Could Intel Double Its Value by 2030?
Intel's turnaround gains traction amid AI-driven demand and a narrowing foundry loss gap, fueling a debate about whet...
Rates Fall Range Investor: What 5% Loans Mean for Homebuyers
Mortgage rates hovering near 5% are shifting the math for buyers and investors alike. This guide breaks down what a r...
Arex Capital Loads Caly: A Bold Bet on CALY Stock
A fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...
Monster Stocks Hold Next: 3 Big Picks for the Next Decade
In a world leaning toward heavy hardware and intelligent systems, you can find durable franchises that may pay off fo...
Why I Wouldn't Claim Social Security Without This Number
Plenty of retirees rush to claim Social Security, but a single number can change everything: your break-even age. Lea...
Biotechnology's Chairman Board Sold: What Investors Know
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
Frontier Capital Makes Stride: A Big Bet on Stride Stock
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
Sonida (SNDA) 2026 Earnings: Q1 Insights & Outlook
A clear, investor-friendly look at Sonida's Q1 2026 performance. We unpack the numbers, the drivers behind them, and ...
Wall Street Ratings on ConocoPhillips May Overshoot Value
ConocoPhillips faces a clash between a wave of Buy ratings and a cautious price target, as crude markets rebound and ...
CFOs Bullish Their Companies—Even as Economy Slows
CFOs are bullish about their own firms even as the broader economy slows, according to Deloitte's Q2 2026 CFO Signals...
Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status